We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Paricalcitol with chemotherapy improved progression-free survival in pancreatic cancer in a phase 1 study. Analysis of Nature Cancer data. Read.
